• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喀麦隆两个地区的肺结核患者治疗前失访情况。

Pre-treatment loss to follow-up of pulmonary tuberculosis patients in two regions of Cameroon.

机构信息

Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei City, Taiwan, AIDS Care and Prevention Program, Cameroon Baptist Convention Health Services.

Faculty of Health Sciences, University of Bamenda, Cameroon.

出版信息

Int J Tuberc Lung Dis. 2018 Apr 1;22(4):378-384. doi: 10.5588/ijtld.17.0676.

DOI:10.5588/ijtld.17.0676
PMID:29562984
Abstract

SETTING

Thirty-nine tuberculosis diagnosis and treatment units (DTUs) in the North-West and South-West Regions of Cameroon.

OBJECTIVE

To determine the proportion of pre-treatment loss to follow-up (PLTFU) of bacteriologically confirmed pulmonary tuberculosis (PTB) patients and its risk factors.

DESIGN

A retrospective cohort study was conducted to retrieve information from the TB laboratory and treatment registers for all bacteriologically confirmed PTB patients diagnosed in the 39 DTUs during the last 6 months of 2015. PLTFU was defined as failure to initiate treatment within 7 days of diagnosis.

RESULTS

Among 1174 bacteriologically confirmed PTB cases, the proportion of PLTFU was 16.7% (95%CI 14.7-18.9). In the multivariable logistic regression model, travelling >30 km to the DTU was a risk factor for PLTFU (adjusted odds ratio [aOR] 2.31, 95%CI 1.63-3.27) compared with travelling 30 km. Travelling for >30 min to the DTU (aOR 2.19, 95%CI 1.56-3.09) and an urban location of DTU (aOR 2.51, 95%CI 1.51-4.17) were also significant risk factors for PLTFU.

CONCLUSION

PLTFU among TB patients remains a significant issue despite the availability of free anti-tuberculosis treatment in Cameroon. Diagnosed patients should be promptly and carefully linked to a treatment unit for treatment initiation.

摘要

背景

喀麦隆西北部和西南部的 39 个结核病诊断和治疗单位(DTU)。

目的

确定经细菌学确诊的肺结核(PTB)患者治疗前失访(PLTFU)的比例及其危险因素。

设计

回顾性队列研究,从 2015 年最后 6 个月的 39 个 DTU 的结核实验室和治疗登记处检索所有经细菌学确诊的 PTB 患者的信息。PLTFU 定义为在诊断后 7 天内未开始治疗。

结果

在 1174 例经细菌学确诊的 PTB 病例中,PLTFU 的比例为 16.7%(95%CI 14.7-18.9)。在多变量逻辑回归模型中,与旅行距离 DTU 30 公里以内相比,旅行距离 DTU 超过 30 公里是 PLTFU 的危险因素(调整后的优势比[aOR] 2.31,95%CI 1.63-3.27)。前往 DTU 超过 30 分钟(aOR 2.19,95%CI 1.56-3.09)和 DTU 位于城市地区(aOR 2.51,95%CI 1.51-4.17)也是 PLTFU 的显著危险因素。

结论

尽管喀麦隆提供免费抗结核治疗,但结核病患者的 PLTFU 仍然是一个严重的问题。应尽快将确诊患者仔细转介到治疗单位以开始治疗。

相似文献

1
Pre-treatment loss to follow-up of pulmonary tuberculosis patients in two regions of Cameroon.喀麦隆两个地区的肺结核患者治疗前失访情况。
Int J Tuberc Lung Dis. 2018 Apr 1;22(4):378-384. doi: 10.5588/ijtld.17.0676.
2
Determinants of death among tuberculosis patients in a semi urban diagnostic and treatment centre of Bafoussam, West Cameroon: a retrospective case-control study.喀麦隆西部巴富萨姆半城市诊断与治疗中心结核病患者死亡的决定因素:一项回顾性病例对照研究
Pan Afr Med J. 2015 Nov 18;22:253. doi: 10.11604/pamj.2015.22.253.6576. eCollection 2015.
3
Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.2007 - 2013年南非西开普省伊登地区结核涂片未转阴的危险因素:一项回顾性队列研究
BMC Infect Dis. 2016 Aug 2;16:365. doi: 10.1186/s12879-016-1712-y.
4
Bacteriologically confirmed pulmonary tuberculosis patients: Loss to follow-up, death and delay before treatment initiation in Bulawayo, Zimbabwe from 2012-2016.2012-2016 年津巴布韦布拉瓦约经细菌学确诊的肺结核患者:失访、死亡和治疗开始前延误情况。
Int J Infect Dis. 2018 Nov;76:6-13. doi: 10.1016/j.ijid.2018.07.012. Epub 2018 Jul 17.
5
Patients' and health system's delays in the diagnosis and treatment of new pulmonary tuberculosis patients in West Gojjam Zone, Northwest Ethiopia: a cross-sectional study.埃塞俄比亚西北部戈贾姆西区新肺结核患者的诊断和治疗中患者及卫生系统的延误:一项横断面研究
BMC Infect Dis. 2016 Nov 11;16(1):673. doi: 10.1186/s12879-016-1995-z.
6
Tuberculosis treatment delays and associated factors within the Zimbabwe national tuberculosis programme.津巴布韦国家结核病规划中的结核病治疗延误及相关因素
BMC Public Health. 2015 Jan 29;15:29. doi: 10.1186/s12889-015-1437-7.
7
Delays in care seeking, diagnosis and treatment among pulmonary tuberculosis patients in Shenzhen, China.中国深圳肺结核患者在寻求医疗、诊断和治疗方面的延误。
Int J Tuberc Lung Dis. 2013 May;17(5):615-20. doi: 10.5588/ijtld.12.0231.
8
Risk factors for tuberculosis treatment failure among pulmonary tuberculosis patients in four health regions of Burkina Faso, 2009: case control study.2009年布基纳法索四个健康地区肺结核患者治疗失败的风险因素:病例对照研究
Pan Afr Med J. 2015 Jun 24;21:152. doi: 10.11604/pamj.2015.21.152.4827. eCollection 2015.
9
Loss-to-follow-up and delay to treatment initiation in Pakistan's national tuberculosis control programme.巴基斯坦国家结核病控制规划中失访和治疗启动延迟。
BMC Public Health. 2018 Mar 9;18(1):335. doi: 10.1186/s12889-018-5222-2.
10
Predictors and mortality associated with treatment default in pulmonary tuberculosis.与肺结核治疗中断相关的预测因素和死亡率。
Int J Tuberc Lung Dis. 2010 Apr;14(4):454-63.

引用本文的文献

1
Patient preferences for empiric TB treatment initiation.患者对经验性抗结核治疗起始的偏好。
Int J Tuberc Lung Dis. 2025 Jan 1;29(1):38-40. doi: 10.5588/ijtld.24.0267.
2
Pre-treatment loss to follow-up in adults with pulmonary TB in Kenya.肯尼亚成年肺结核患者治疗前失访情况
Public Health Action. 2024 Mar 1;14(1):34-39. doi: 10.5588/pha.23.0059. eCollection 2024 Mar.
3
Causes of pre-treatment loss to follow-up in patients with TB.结核病患者治疗前失访的原因。
Public Health Action. 2022 Dec 21;12(4):148-152. doi: 10.5588/pha.22.0051.
4
Differences in CT imaging signs between patients with tuberculosis and those with tuberculosis and concurrent lung cancer.肺结核患者与肺结核合并肺癌患者的CT影像征象差异。
Am J Transl Res. 2022 Sep 15;14(9):6234-6242. eCollection 2022.
5
Factors associated with loss to follow-up among TB patients in rural Papua New Guinea.巴布亚新几内亚农村地区结核病患者失访的相关因素。
Public Health Action. 2021 Dec 21;11(4):186-190. doi: 10.5588/pha.21.0054.
6
Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012-2019: Are We on the Right Track?乌兹别克斯坦 2012-2019 年耐药结核病分子诊断检测扩大化:我们是否走在正确的轨道上?
Int J Environ Res Public Health. 2021 Apr 28;18(9):4685. doi: 10.3390/ijerph18094685.
7
Pre-treatment lost to follow-up tuberculosis patients, Chongwe, Zambia, 2017: a retrospective cohort study.2017年赞比亚琼圭地区治疗前失访的结核病患者:一项回顾性队列研究
Public Health Action. 2020 Mar 21;10(1):21-26. doi: 10.5588/pha.19.0059.
8
The Growing Importance of Tuberculosis Preventive Therapy and How Research and Innovation Can Enhance Its Implementation on the Ground.结核病预防治疗的重要性日益凸显以及研究与创新如何能加强其在实际中的实施
Trop Med Infect Dis. 2020 Apr 16;5(2):61. doi: 10.3390/tropicalmed5020061.
9
Where are patients missed in the tuberculosis diagnostic cascade? A prospective cohort study in Ghana.结核病诊断环节中的漏诊患者在哪里?加纳的一项前瞻性队列研究。
PLoS One. 2020 Mar 19;15(3):e0230604. doi: 10.1371/journal.pone.0230604. eCollection 2020.
10
Mobile targeted screening for tuberculosis in Zimbabwe: diagnosis, linkage to care and treatment outcomes.津巴布韦的移动结核病靶向筛查:诊断、与治疗的联系及治疗结果
Public Health Action. 2019 Dec 21;9(4):159-165. doi: 10.5588/pha.19.0040.